切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2014, Vol. 03 ›› Issue (04) : 253 -256. doi: 10.3877/cma.j.issn.2095-3224.2014.04.06

所属专题: 文献

专家论坛

小肠移植缺血再灌注损伤的防治策略
邹小明1,(), 李晓林1   
  1. 1. 150086 哈尔滨医科大学附属第二医院普外科二病房
  • 收稿日期:2014-07-15 出版日期:2014-08-25
  • 通信作者: 邹小明
  • 基金资助:
    哈尔滨市科技攻关计划项目(2005AA9CS116-7)

Strutegies for the prevention of ischemia reperfusion injury caused by small bowel transplantation

Xiao-ming ZHOU1,(), Xiao-lin LI1   

  1. 1. The Second Deparement of General Surery, the Second Hospital of Harbin Medical University, Harbin 10086, China
  • Received:2014-07-15 Published:2014-08-25
  • Corresponding author: Xiao-ming ZHOU
  • About author:
    Corresponding author: ZHOU Xiao-ming, Email:
引用本文:

邹小明, 李晓林. 小肠移植缺血再灌注损伤的防治策略[J/OL]. 中华结直肠疾病电子杂志, 2014, 03(04): 253-256.

Xiao-ming ZHOU, Xiao-lin LI. Strutegies for the prevention of ischemia reperfusion injury caused by small bowel transplantation[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2014, 03(04): 253-256.

小肠对缺血敏感,术后缺血再灌注损伤(I/R)严重,影响临床小肠移植的效果。缺血预处理(IPC)、改善小肠移植保存液、抗炎等多种方法对减轻I/R显示出广阔前景,但均处于实验阶段,结合我们的研究,本文概括介绍了抗小肠I/R的方法及策略。

The intestine is extremely sensitive to ischemia; and the severe I/R after intestinal transplantation defects the effect of intestinal transplantation.A variety of methods show broad prospects, such as ischemic-preconditioning, improving preservation solution, and using anti-inflammatory drugs in the experimental stage.Combined with our research, the study reviews current methods and strategies for attenuating I/R of intestine.

[1]
Abu-Elmagd KM,Costa G,Bond G J, et al.Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.Transpl Int, 2009, 22(1): 96-109.
[2]
李元新. 小肠移植的现状和进展-来自第11届国际小肠移植大会的报告. 器官移植, 2010, 1(1)56-60.
[3]
Roskott AM,Nieuwenhuijs VB,Dijkstra G, et al.Small bowel preservation for intestinal transplantation.Transpl Int, 2011, 24(2): 107-31.
[4]
Cicalese L,Sileri P,Green M, et al.Bacterial translocation in clinical intestinal transplantation.Transplantation, 2001, 71(10): 1414-1417.
[5]
Mallick IH,Yang W,Winslet MC, et al.Ischemia-reperfusion injury of the intestine and protective strategies against injury.Dig Dis Sci, 2004, 49(9): 1359-1377.
[6]
Sileri P,Morini S,Schena S, et al.Intestinal ischemia/reperfusion injury produces chronic abnormalities of absorptive function.Transplant Proc, 2002, 34(3): 984.
[7]
宋茂力,邹小明. 肠I/R防治的研究进展. 中国比较医学杂志, 2007, 17(7): 417-420.
[8]
Wu B,Ootani A,Iwakiri R, et al.Ischemic preconditioning attenuates ischemia-reperfusi-on-induced mucosal apoptosis by inhibiting the mitochondria–dependent pathway in rat small intestine.Am J Gastrointest Liver Physiol, 2004, 286(4): 580-587.
[9]
Mallick IH,Yang W,Winslet, et al.Ischaemic preconditioning improves microvascular perfusion and oxygenation following reperfusion injury of the intestine.Br J Surg, 2005, 92(9): 1169-1176.
[10]
Riksen NP,Smits P,Rongen GA.I schaemic preconditioning:from molecular characterisation to clinical application-part I. Neth J Med, 2004, 62(10): 353-363.
[11]
Ito K,Ozasa H,Kojima N, et al.Pharmacological preconditioning protects lung injury induced by intestinal ischemia/reperfusion in rat.Shock, 2003, 19: 462-468.
[12]
Santos CH,Gomes OM,Pontes JC, et al.The ischemic preconditioning and postconditioning effect on the intestinal mucosa of rats undergoing mesenteric ischemia/reperfusion procedure.Acta Cir Bras, 2008, 23(1): 22-28.
[13]
Roskott AM,Nieuwenhuijs VB,Dijkstra G, et al.Small bowel preservation for intestinal transplantation.Transpl Int, 2011, 24(2): 107-131.
[14]
Heidenhain C,Pratschke J,Puhl G, et al.Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation.Transplant international, 2010, 23(1): 14-22.
[15]
Morariu AM,Vd Plaats A,Oeveren V W, et al.Hyperaggregating effect of hydroxyethyl starch components andUniversity of Wisconsin solution on human red blood cells:a risk of impaired graft perfusion in organ procurement? Transplantation, 2003, 76(1): 37-43.
[16]
宋茂力,邹小明,李刚, 等. 羟乙基淀粉对猪小肠I/R保护作用的研究. 中华实验外科杂志, 2007, 24(12): 1543-1544.
[17]
Li XL,Zou XM,Gang Nie, et al.Role ofhydroxyethl starch in ischemic reperfusion injury in rat intestinal transplantation.Transplant Proc, 2013, 45(6): 2490-2495.
[18]
Azuara D,Sola A,Hotter G, et al.Administration of nitric oxide with caspase inhibitors minimizes bacterial translocation in experimental intestinal transplantation.Transplantation, 2004, 77(2): 177-183.
[19]
Li XL,Zou XM,Gao P, et al.Role of nitric oxide in ischemia-reperfusion injury and acute rejection in rat intestinal transplantation.Transplant Proc, 2008, 40(10): 3342-3345.
[20]
李晓林,邹小明,宋茂力, 等. L-NAME在大鼠小肠移植急性排斥反应中作用的研究. 中华实验外科杂志, 2010, 27(5): 675.
[21]
李晓林,邹小明,李刚, 等. 一氧化氮在大鼠小肠移植I/R和急性排斥反应中的作用. 中华器官移植杂志, 2012, 33(1): 48-52.
[22]
李晓林,邹小明,李云龙, 等. 一氧化氮合成酶在大鼠小肠移植急性排斥反应中的作用. 中华实验外科杂志, 2012, 29(1): 86-88.
[23]
Li XL,Zou XM,Gang Nie, et al.Roles of nNOS and iNOS in intestinal transplantation of rats.Transplant Proc, 2013, 45(6): 2496-2500.
[24]
Kojima M,Iwakiri R,Wu B, et al.Effects of antioxidative agents on apoptosis induced by ischaemia-reperfusion in rat intestinal mucosa.Aliment Pharmacol Ther, 2003, 18(1): 139-145.
[25]
胡森,姜小国,石德光, 等. 卡巴胆碱对缺血-再灌注损伤时肠道局部炎症反应的影响. 中国危重病急救医学, 2003, 15(12): 748-750.
[26]
Zhao H,Montalto MC,Pfeiffer KJ, et al.Murine model of gastrointestinal ischemia associated with complementdependent injury.J Appl Physiol, 2002, 93(1): 338-345.
[27]
Sola A,Alfaro V,Pesquero J, et al.CO2 in static mesenteric venous blood during intestinal ischemia and ischemic preconditioning in rats.Shock, 2001, 16(5): 403-408.
[28]
O’Donnell KA,Caty MG,Shan Zheng, et al.Oxygenated intralumnal perfluorocarbon protects intestinal muscosa from Ischemia/Reperfusion injury.J Pediatr Surg, 1997, 32: 361.
[29]
Fukatsu K,Zarzaur BL,Johnson CD, et al.Enteral nutrition prevents remote organ injury and death after a gut ischemic insult.Ann Surg, 2001, 233(5): 660-668.
[30]
Inoue T,Saito H,Fukushima R, et al.Growth hormone and insulinlike growth factor enhance host defense in a murine sepsis model.Arch Surg, 1995, 130: 1115-1122.
[31]
吴国生. 临床活体小肠移植国内外研究进展. 中华结直肠疾病电子杂志, 2013, 2(5): 221-223.
[1] 周容, 张亚萍, 廖宇, 程晓萍, 管玉龙, 潘广玉, 闫杰, 王贤芝, 苟中山, 潘登科, 李巅远. 超声在基因编辑猪-猴异种并联式心脏移植术中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 617-623.
[2] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[3] 中华医学会器官移植学分会. 遗体捐献肾脏获取手术技术操作指南[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 257-265.
[4] 邹永康, 石雍, 徐贤刚, 张帅民, 刘衍, 杨生鹏, 叶啟发, 陈根, 张毅. 肾移植术后手术切口米根霉感染伴菌血症一例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 289-292.
[5] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[6] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[7] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[8] 郭倩男, 史嘉玮, 董念国. T细胞不同代谢方式在移植排斥反应中的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 315-320.
[9] 中华医学会器官移植学分会. 中国肺移植气道并发症临床诊疗指南(2024版)[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 266-274.
[10] 黄莹, 李璇, 刘梦杨, 彭桂林, 徐鑫, 韦兵, 杨超. 靶向联合治疗双肺移植术后KRAS和BRAF基因双突变晚期肺腺癌一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 298-301.
[11] 孙璐, 蒋亚玲, 陈凌君. 布托啡诺对脑缺血再灌注损伤大鼠神经炎症和JAK2/STAT3信号通路的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 344-350.
[12] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[13] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[14] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[15] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?